Replies to post #48228 on Biotech Values

[DewDiligence]

> AGIX – …possible that 1067 would get a black box label for diabetes (presumably due to the liver tox issues). IMO he/they are to be commended for being that honest<

This may be less consequential from a competitive standpoint given that black-box warnings will soon be added to Avandia, Actos, and perhaps other diabetes meds.